SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$1.65
-0.10 (-5.71%)
As of Sep 28, 10:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
200.3K
Net Income
-11,746,619
Gross Margin
38.6%
Profit Margin
-5,863.7%
Rev Growth
+1.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.6% 38.6% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.2% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 200.3K 198.3K 653.1K 554.3K
Gross Profit 77.2K 76.5K 417.2K 354.1K
Operating Income -12,003,237 -10,697,012 118.9K 110.9K
Net Income -11,746,619 -10,468,320 116.0K 91.5K
Gross Margin 38.6% 38.6% 63.9% 63.9%
Operating Margin -5,992.5% -5,393.2% 18.2% 20.0%
Profit Margin -5,863.7% -5,570.5% 17.8% 16.5%
Rev Growth +1.0% +1.0% -9.1% -7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 583.1K 550.9K
Total Equity — — 1.94M 1.85M
D/E Ratio — — 0.30 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -12,004,687 -11,292,655 172.6K 151.1K
Free Cash Flow — — 101.3K 71.5K